相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Depression and inflammation: Correlation between changes in inflammatory markers with antidepressant response and long-term prognosis
Joakim Kofod et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2022)
Dissecting the Association Between Inflammation, Metabolic Dysregulation, and Specific Depressive Symptoms A Genetic Correlation and 2-Sample Mendelian Randomization Study
Nils Kappelmann et al.
JAMA PSYCHIATRY (2021)
Impact of Supplementation and Nutritional Interventions on Pathogenic Processes of Mood Disorders: A Review of the Evidence
Cara T. Hoepner et al.
NUTRIENTS (2021)
Childhood trauma, HPA axis activity and antidepressant response in patients with depression
Naghmeh Nikkheslat et al.
BRAIN BEHAVIOR AND IMMUNITY (2020)
Prospective biomarkers of major depressive disorder: a systematic review and meta-analysis
Mitzy Kennis et al.
MOLECULAR PSYCHIATRY (2020)
Whole-blood expression of inflammasome- and glucocorticoid-related mRNAs correctly separates treatment-resistant depressed patients from drug-free and responsive patients in the BIODEP study
Annamaria Cattaneo et al.
TRANSLATIONAL PSYCHIATRY (2020)
Value of peripheral neurotrophin levels for the diagnosis of depression and response to treatment: A systematic review and meta-analysis
Yachen Shi et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2020)
Short and long-term treatment outcomes of stepwise psychopharmacotherapy based on early clinical decision in patients with depressive disorders
Jae-Min Kim et al.
JOURNAL OF AFFECTIVE DISORDERS (2020)
A systematic meta-review of predictors of antidepressant treatment outcome in major depressive disorder
Kelly Perlman et al.
JOURNAL OF AFFECTIVE DISORDERS (2019)
Sex differences in the association of baseline c-reactive protein (CRP) and acute-phase treatment outcomes in major depressive disorder: Findings from the EMBARC study
Manish K. Jha et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2019)
Plasma serotonin levels are associated with antidepressant response to SSRIs
Amanda Holck et al.
JOURNAL OF AFFECTIVE DISORDERS (2019)
Biomarkers for response in major depression: comparing paroxetine and venlafaxine from two randomised placebo-controlled clinical studies
Lucia Carboni et al.
TRANSLATIONAL PSYCHIATRY (2019)
Validating pre-treatment body mass index as moderator of antidepressant treatment outcomes: Findings from CO-MED trial
Manish K. Jha et al.
JOURNAL OF AFFECTIVE DISORDERS (2018)
Transcriptomic and epigenomic biomarkers of antidepressant response
Raoul Belzeaux et al.
JOURNAL OF AFFECTIVE DISORDERS (2018)
Peripheral biomarkers of major depression and antidepressant treatment response: Current knowledge and future outlooks
Bharathi S. Gadad et al.
JOURNAL OF AFFECTIVE DISORDERS (2018)
The MAKE Biomarker Discovery for Enhancing anTidepressant Treatment Effect and Response (MAKE BETTER) Study: Design and Methodology
Hee-Ju Kang et al.
PSYCHIATRY INVESTIGATION (2018)
Genetic Contributions of Inflammation to Depression
Jacob Barnes et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Can C-reactive protein inform antidepressant medication selection in depressed outpatients? Findings from the CO-MED trial
Manish K. Jha et al.
PSYCHONEUROENDOCRINOLOGY (2017)
Biomarkers for depression: recent insights, current challenges and future prospects
Rebecca Strawbridge et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2017)
Antidepressant prescribing in the precision medicine era: a prescriber's primer on pharmacogenetic tools
Chad A. Bousman et al.
BMC PSYCHIATRY (2017)
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments
Sidney H. Kennedy et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2016)
Agomelatine Increases BDNF Serum Levels in Depressed Patients in Correlation with the Improvement of Depressive Symptoms
Giovanni Martinotti et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2016)
Ghrelin's Role in the Hypothalamic-Pituitary-Adrenal Axis Stress Response: Implications for Mood Disorders
Sarah J. Spencer et al.
BIOLOGICAL PSYCHIATRY (2015)
Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder
Rita Haapakoski et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
Inflammation and clinical response to treatment in depression: A meta-analysis
R. Strawbridge et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
Association of Obesity and Inflammatory Marker Levels on Treatment Outcome: Results From a Double-Blind, Randomized Study of Adjunctive L-Methylfolate Calcium in Patients With MDD Who Are Inadequate Responders to SSRIs
Richard C. Shelton et al.
JOURNAL OF CLINICAL PSYCHIATRY (2015)
Resistance to antidepressant treatment is associated with polymorphisms in the leptin gene, decreased leptin mRNA expression, and decreased leptin serum levels
Stefan Kloiber et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2013)
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Update 2013 on the acute and continuation treatment of unipolar depressive disorders
Michael Bauer et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2013)
A neurotrophic hypothesis of depression: role of synaptogenesis in the actions of NMDA receptor antagonists
Ronald S. Duman et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2012)
Predictors of 12-week remission in a nationwide cohort of people with depressive disorders: the CRESCEND study
Jae-Min Kim et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2011)
Functional Biomarkers of Depression: Diagnosis, Treatment, and Pathophysiology
Heath D. Schmidt et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Multiple biomarkers for the prediction of first major cardiovascular events and death
Thomas J. Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
EQ-5D: a measure of health status from the EuroQol Group
R Rabin et al.
ANNALS OF MEDICINE (2001)
分享论文
